Bio-Techne Corp (TECH) Social Stream
BIO-TECHNE CORP (TECH) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering BIO-TECHNE CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-02 | 9 | $600 | $400 | $510.625 | $73.14 | 598.15% |
| 2021-12-01 | 9 | $600 | $400 | $511.875 | $73.14 | 599.86% |
| 2022-02-01 | 9 | $600 | $410 | $542.5 | $73.14 | 641.73% |
| 2022-03-01 | 6 | $600 | $540 | $565 | $73.14 | 672.49% |
| 2022-04-25 | 7 | $600 | $370 | $532.5 | $73.14 | 628.06% |
| 2022-05-05 | 7 | $575 | $370 | $513.571 | $73.14 | 602.18% |
| 2022-06-06 | 6 | $575 | $370 | $506.428 | $73.14 | 592.41% |
| 2022-08-04 | 6 | $580 | $370 | $507.142 | $73.14 | 593.39% |
| 2022-08-05 | 6 | $580 | $370 | $491.428 | $73.14 | 571.9% |
| 2022-09-22 | 6 | $580 | $360 | $490 | $73.14 | 569.95% |
| 2022-10-19 | 6 | $550 | $360 | $485.714 | $73.14 | 564.09% |
| 2022-11-01 | 6 | $550 | $360 | $477.142 | $73.14 | 552.37% |
| 2022-11-02 | 6 | $500 | $360 | $442.5 | $73.14 | 505% |
| 2022-12-05 | 6 | $125 | $90 | $110.625 | $73.14 | 51.25% |
| 2022-12-07 | 7 | $125 | $89 | $108.222 | $73.14 | 47.97% |
| 2022-12-12 | 8 | $125 | $89 | $107.4 | $73.14 | 46.84% |
| 2023-01-06 | 9 | $125 | $89 | $106.727 | $73.14 | 45.92% |
| 2023-02-03 | 9 | $120 | $89 | $103.318 | $73.14 | 41.26% |
| 2023-02-14 | 9 | $120 | $88 | $103.227 | $73.14 | 41.14% |
| 2023-03-27 | 9 | $120 | $88 | $102.772 | $73.14 | 40.51% |
| 2023-05-01 | 8 | $120 | $88 | $102.772 | $73.14 | 40.51% |
| 2023-05-04 | 9 | $120 | $90 | $102.954 | $73.14 | 40.76% |
| 2023-08-09 | 9 | $120 | $90 | $103.045 | $73.14 | 40.89% |
| 2023-08-16 | 9 | $120 | $90 | $102.159 | $73.14 | 39.68% |
| 2023-08-25 | 10 | $120 | $90 | $102.159 | $73.14 | 39.68% |
| 2023-09-12 | 11 | $120 | $90 | $102.159 | $73.14 | 39.68% |
| 2023-10-18 | 11 | $120 | $86 | $101.795 | $73.14 | 39.18% |
| 2023-10-31 | 11 | $120 | $86 | $100.886 | $73.14 | 37.94% |
| 2023-11-03 | 11 | $120 | $65 | $84.6 | $73.14 | 15.67% |
| 2023-11-17 | 11 | $120 | $65 | $81.6 | $73.14 | 11.57% |
| 2023-12-06 | 11 | $120 | $65 | $79.2 | $73.14 | 8.29% |
| 2023-12-18 | 12 | $120 | $65 | $79.272 | $73.14 | 8.38% |
| 2023-12-29 | 12 | $120 | $65 | $80.909 | $73.14 | 10.62% |
The Trend in the Analyst Price Target
Over the past 14 months, TECH's average price target has gone down $396.23.
TECH reports an average of 33.58% for its upside potential over the past 48 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-08-02 | 9 | 120 | 90 | 103.045 | 82.02 | 25.63% |
| 2023-08-21 | 10 | 120 | 90 | 102.159 | 78.68 | 29.84% |
| 2023-09-08 | 11 | 120 | 90 | 102.159 | 71.82 | 42.24% |
| 2023-10-30 | 11 | 120 | 86 | 100.886 | 56.64 | 78.12% |
| 2023-11-10 | 11 | 120 | 65 | 81.600 | 57.49 | 41.94% |
TECH Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.33 | 10 | 0 | 2 | 0 | 0 | 12 |
The Trend in the Broker Recommendations
TECH's average broker recommendation rating improved by 0.55 over the prior 47 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, BIO-TECHNE CORP's average analyst price target is higher than 3553.28% of them.
- BIO-TECHNE CORP's upside potential (average analyst target price relative to current price) is greater than 3499.57% of stocks in the large market cap category.
- TECH has a greater number of analysts covering the stock than 751.73% of stocks in the large market cap category.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, BIO-TECHNE CORP's variance in analysts' estimates is lower than -847.81% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to BIO-TECHNE CORP are RGEN, AMGN, and DNA.
View All Top Stocks by Price Target
Make investment decisions regarding TECH using the data that counts. Try POWR Ratings for free.